File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Effects of pertussis toxin on electroacupuncture-produced anti-hyperalgesia in inflamed rats

TitleEffects of pertussis toxin on electroacupuncture-produced anti-hyperalgesia in inflamed rats
Authors
KeywordsAcupuncture
Analgesia
Complete Freund's adjuvant
Hyperalgesia
Pertussis toxin
Rat
Spinal cord
Issue Date2005
PublisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/brainres
Citation
Brain Research, 2005, v. 1044 n. 1, p. 87-92 How to Cite?
AbstractOur previous study showed that electroacupuncture (EA) significantly attenuated hyperalgesia in an animal model of persistent inflammatory pain. The present study was designed to show if Gi/o protein is involved in EA-produced anti-hyperalgesia. Spinal Gi/o-protein function was destroyed by intrathecal pretreatment with pertussis toxin (PTX). Seven days after the placement of an intrathecal PE-10 tube, PTX was injected into the intrathecal space of the lumbar spinal cord of rats. Seven days after PTX, complete Freund's adjuvant (CFA) was injected into the plantar surface of one hind paw of the rat to induce hyperalgesia in the injected paw. EA treatment was given at acupoint GB30 immediately post-CFA and then hyperalgesia was assessed by measuring the degree of decreased paw withdrawal latency (PWL) to a noxious thermal stimulus. The results showed that PTX pretreatment prevented EA-produced anti-hyperalgesia in the CFA inflammatory pain model but did not affect either baseline pain threshold or CFA-induced hyperalgesia. The data suggest that EA-produced anti-hyperalgesia is mediated by PTX-sensitive Gi/o proteins and the relevant signaling pathways. © 2005 Elsevier B.V. All rights reserved.
Persistent Identifierhttp://hdl.handle.net/10722/188564
ISSN
2023 Impact Factor: 2.7
2023 SCImago Journal Rankings: 0.832
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorLiu, Ben_US
dc.contributor.authorZhang, RXen_US
dc.contributor.authorWang, Len_US
dc.contributor.authorRen, Ken_US
dc.contributor.authorQiao, JTen_US
dc.contributor.authorBerman, BMen_US
dc.contributor.authorLao, Len_US
dc.date.accessioned2013-09-03T04:10:18Z-
dc.date.available2013-09-03T04:10:18Z-
dc.date.issued2005en_US
dc.identifier.citationBrain Research, 2005, v. 1044 n. 1, p. 87-92en_US
dc.identifier.issn0006-8993en_US
dc.identifier.urihttp://hdl.handle.net/10722/188564-
dc.description.abstractOur previous study showed that electroacupuncture (EA) significantly attenuated hyperalgesia in an animal model of persistent inflammatory pain. The present study was designed to show if Gi/o protein is involved in EA-produced anti-hyperalgesia. Spinal Gi/o-protein function was destroyed by intrathecal pretreatment with pertussis toxin (PTX). Seven days after the placement of an intrathecal PE-10 tube, PTX was injected into the intrathecal space of the lumbar spinal cord of rats. Seven days after PTX, complete Freund's adjuvant (CFA) was injected into the plantar surface of one hind paw of the rat to induce hyperalgesia in the injected paw. EA treatment was given at acupoint GB30 immediately post-CFA and then hyperalgesia was assessed by measuring the degree of decreased paw withdrawal latency (PWL) to a noxious thermal stimulus. The results showed that PTX pretreatment prevented EA-produced anti-hyperalgesia in the CFA inflammatory pain model but did not affect either baseline pain threshold or CFA-induced hyperalgesia. The data suggest that EA-produced anti-hyperalgesia is mediated by PTX-sensitive Gi/o proteins and the relevant signaling pathways. © 2005 Elsevier B.V. All rights reserved.en_US
dc.languageengen_US
dc.publisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/brainresen_US
dc.relation.ispartofBrain Researchen_US
dc.subjectAcupuncture-
dc.subjectAnalgesia-
dc.subjectComplete Freund's adjuvant-
dc.subjectHyperalgesia-
dc.subjectPertussis toxin-
dc.subjectRat-
dc.subjectSpinal cord-
dc.subject.meshAnimalsen_US
dc.subject.meshBehavior, Animalen_US
dc.subject.meshCalcitonin Gene-Related Peptide - Metabolismen_US
dc.subject.meshElectroacupuncture - Methodsen_US
dc.subject.meshFreund's Adjuvanten_US
dc.subject.meshHyperalgesia - Etiology - Therapyen_US
dc.subject.meshImmunohistochemistry - Methodsen_US
dc.subject.meshInflammation - Chemically Induced - Complications - Therapyen_US
dc.subject.meshInjections, Spinal - Methodsen_US
dc.subject.meshLectins - Metabolismen_US
dc.subject.meshMaleen_US
dc.subject.meshPain Measurementen_US
dc.subject.meshPertussis Toxin - Administration & Dosageen_US
dc.subject.meshRatsen_US
dc.subject.meshRats, Sprague-Dawleyen_US
dc.subject.meshReaction Time - Drug Effects - Radiation Effectsen_US
dc.subject.meshSubstance P - Metabolismen_US
dc.titleEffects of pertussis toxin on electroacupuncture-produced anti-hyperalgesia in inflamed ratsen_US
dc.typeArticleen_US
dc.identifier.emailLao, L: lxlao1@hku.hken_US
dc.identifier.authorityLao, L=rp01784en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1016/j.brainres.2005.03.006en_US
dc.identifier.pmid15862793-
dc.identifier.scopuseid_2-s2.0-18144422816en_US
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-18144422816&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume1044en_US
dc.identifier.issue1en_US
dc.identifier.spage87en_US
dc.identifier.epage92en_US
dc.identifier.isiWOS:000229276700011-
dc.publisher.placeNetherlandsen_US
dc.identifier.scopusauthoridLiu, B=55720712900en_US
dc.identifier.scopusauthoridZhang, RX=7404864527en_US
dc.identifier.scopusauthoridWang, L=9036448600en_US
dc.identifier.scopusauthoridRen, K=7102272533en_US
dc.identifier.scopusauthoridQiao, JT=7103301572en_US
dc.identifier.scopusauthoridBerman, BM=35458606800en_US
dc.identifier.scopusauthoridLao, L=7005681883en_US
dc.identifier.issnl0006-8993-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats